- Design and perform proof-of-mechanism as well as proof-of-concept gene editing studies.
- Hands-on execution of in vitro, ex vivo, and in vivo assays to analyze gene editing of development candidates.
- Perform cell biology, molecular biology, and biochemistry analyses.
- Analyze, interpret, and present experimental data.
- Collaborate with colleagues to ensure timeline adherence and project alignment to meet group and company goals.
- Support external and internal projects via team meetings, presentations, and reports.
- Attention to detail and ability to operate independently.
- Excellent communication and record keeping skills.
- A PhD degree, or equivalent, with 3-5 years of post-doctoral training or industrial experience.
- Strong background in mammalian gene therapy/editing, RNA biology, DNA repair or related fields.
- Hands-on experience with a broad range of cell and molecular biology techniques.
- Experienced with mammalian cell culture (primary cells and cell lines), transient transfections, standard molecular cloning techniques, and cell-based assays.
- Ability to multitask and readily adapt to change.
- Familiarity with the field of hematopoiesis and hematological diseases.
- Experience manipulating primary human hematopoietic cells.
- Experience with gene-editing (CRISPR/Cas9, ZFNs, TALENs) and DNA/RNA/protein delivery.
- Knowledge in DNA repair mechanisms and pathways.
- Broad conceptual expertise with genomics technologies and hands-on expertise with assays including microarray analyses, digital PCR and QPCR, and next-gen sequencing.
- Experience in FACS, Luminex multiplex assays, and IHC/ICC/IF.